Wikidata

(Q82892718)

English

Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, given weekly to advanced solid tumor patients for 3 weeks

scientific article published on 01 February 2009

In more languages

Statements

title
Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, given weekly to advanced solid tumor patients for 3 weeks (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
19068085
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19068085%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q82892718&oldid=1758395707"